Wanbury appoints Prakash Venkatraman as President of API Business
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Our centers are performing as expected or even better
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
To co-develop and co-commercialize MK-6070, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager, worldwide except for Japan where Merck retains exclusive rights
Revolutionary technology will further boost OneSource’s scientific services offerings
Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Subscribe To Our Newsletter & Stay Updated